See more : Public Service Company of New Mexico PFD 4.58% (PNMXO) Income Statement Analysis – Financial Results
Complete financial analysis of PT Kimia Farma (Persero) Tbk (KAEF.JK) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of PT Kimia Farma (Persero) Tbk, a leading company in the Medical – Distribution industry within the Healthcare sector.
- Hangzhou Tigermed Consulting Co., Ltd. (3347.HK) Income Statement Analysis – Financial Results
- Seagate Technology Holdings plc (0Y2A.L) Income Statement Analysis – Financial Results
- Golden Cross Resources Limited (GCR.AX) Income Statement Analysis – Financial Results
- QL Resources Berhad (7084.KL) Income Statement Analysis – Financial Results
- Craftsman Automation Limited (CRAFTSMAN.BO) Income Statement Analysis – Financial Results
PT Kimia Farma (Persero) Tbk (KAEF.JK)
About PT Kimia Farma (Persero) Tbk
PT Kimia Farma (Persero) Tbk produces and sells medicines, herbal medicines, iodine, salts, quinine and their derivative products, and vegetable oils in Indonesia. The company operates through Manufacturing, Distribution, Retail, and Other Services segments. It also manufactures and sells generic, ethical, license and narcotic medicines, and over the counter medicines, health equipment, raw materials, medicines, medical devices, and cosmetics. In addition, the company distributes its products in drug to pharmacies, hospital pharmacy installation, medical center, and drug stores. The company was founded in 1817 and is headquartered in Jakarta, Indonesia.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 9,965.03B | 9,606.15B | 12,857.63B | 10,006.17B | 9,400.54B | 7,454.11B | 6,127.48B | 5,811.50B | 4,860.37B | 4,521.02B | 4,348.07B | 3,734.24B | 3,481.17B | 3,183.83B | 2,854.06B | 2,704.73B |
| Cost of Revenue | 7,184.76B | 6,013.31B | 8,461.34B | 6,349.04B | 5,897.25B | 4,673.94B | 3,925.60B | 3,947.61B | 3,323.62B | 3,135.54B | 3,055.92B | 2,559.07B | 2,443.15B | 2,279.31B | 2,065.81B | 1,982.48B |
| Gross Profit | 2,780.27B | 3,592.84B | 4,396.29B | 3,657.13B | 3,503.29B | 2,780.18B | 2,201.88B | 1,863.90B | 1,536.75B | 1,385.48B | 1,292.15B | 1,175.17B | 1,038.02B | 904.52B | 788.25B | 722.25B |
| Gross Profit Ratio | 27.90% | 37.40% | 34.19% | 36.55% | 37.27% | 37.30% | 35.93% | 32.07% | 31.62% | 30.65% | 29.72% | 31.47% | 29.82% | 28.41% | 27.62% | 26.70% |
| Research & Development | 100.97B | 46.37B | 41.35B | 15.53B | 15.32B | 18.07B | 37.43B | 24.45B | 19.13B | 15.27B | 17.25B | 14.79B | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 573.59B | 321.91B | 378.34B | 416.36B | 485.09B | 302.07B | 246.11B | 195.81B | 172.56B | 180.31B | 143.99B | 123.79B | 328.04B | 321.24B | 282.47B | 258.72B |
| Selling & Marketing | 890.45B | 669.49B | 651.01B | 752.09B | 939.97B | 526.95B | 439.86B | 310.23B | 237.61B | 125.74B | 236.67B | 212.81B | 487.97B | 437.08B | 393.84B | 356.49B |
| SG&A | 4,027.63B | 991.40B | 1,029.35B | 1,168.45B | 1,425.05B | 829.03B | 685.97B | 506.04B | 410.17B | 875.03B | 380.66B | 336.60B | 816.01B | 758.32B | 676.32B | 615.21B |
| Other Expenses | 221.92B | 2,202.99B | 2,401.01B | 1,980.05B | 1,771.48B | 118.84B | 76.48B | 37.26B | 34.30B | 47.59B | 22.74B | 17.61B | 0.00 | 43.07B | 0.00 | 0.00 |
| Operating Expenses | 4,350.52B | 3,240.76B | 3,471.71B | 3,164.03B | 3,211.86B | 2,183.97B | 1,777.81B | 1,459.86B | 1,219.61B | 1,099.83B | 1,042.62B | 912.60B | 816.01B | 758.32B | 676.32B | 615.21B |
| Cost & Expenses | 11,535.28B | 9,254.07B | 11,933.05B | 9,513.07B | 9,109.10B | 6,857.91B | 5,703.41B | 5,407.47B | 4,543.23B | 4,235.37B | 4,098.54B | 3,471.67B | 3,259.16B | 3,037.63B | 2,742.12B | 2,597.69B |
| Interest Income | 25.45B | 12.16B | 14.06B | 16.71B | 34.63B | 36.87B | 15.76B | 8.31B | 12.03B | 6.66B | 3.70B | 2.55B | 1.41B | 1.41B | 433.85M | 2.86B |
| Interest Expense | 622.82B | 520.61B | 606.81B | 596.38B | 497.97B | 187.29B | 85.95B | 59.80B | 35.62B | 26.87B | 9.25B | 6.81B | 11.31B | 13.49B | 24.28B | 16.12B |
| Depreciation & Amortization | 321.15B | 510.53B | 391.77B | 244.36B | 159.66B | 178.52B | 72.71B | 60.08B | 27.79B | 39.54B | 17.75B | 19.72B | 0.00 | 0.00 | -12.26B | -8.73B |
| EBITDA | -1,223.65B | 1,019.75B | 1,391.47B | 914.09B | 695.94B | 1,161.03B | 608.37B | 492.86B | 418.84B | 379.72B | 293.89B | 304.82B | 260.72B | 146.20B | 99.67B | 98.31B |
| EBITDA Ratio | -12.28% | 8.27% | 9.56% | 8.17% | 6.43% | 11.30% | 9.44% | 8.45% | 8.40% | 7.58% | 6.76% | 8.06% | 6.38% | 4.59% | 3.49% | 3.63% |
| Operating Income | -1,570.25B | 558.07B | 985.64B | 653.02B | 501.66B | 765.02B | 535.66B | 442.82B | 374.28B | 342.48B | 293.77B | 285.16B | 222.00B | 146.20B | 111.93B | 107.04B |
| Operating Income Ratio | -15.76% | 5.81% | 7.67% | 6.53% | 5.34% | 10.26% | 8.74% | 7.62% | 7.70% | 7.58% | 6.76% | 7.64% | 6.38% | 4.59% | 3.92% | 3.96% |
| Total Other Income/Expenses | -597.37B | -513.44B | -592.76B | -579.67B | -463.34B | -189.39B | -85.95B | -59.80B | -36.14B | -26.87B | -9.64B | -1.89B | 10.00B | 32.41B | -12.20B | -10.93B |
| Income Before Tax | -2,167.61B | 49.62B | 392.88B | 73.36B | 38.32B | 577.73B | 449.71B | 383.03B | 338.14B | 315.61B | 284.13B | 278.28B | 232.01B | 178.61B | 99.73B | 96.11B |
| Income Before Tax Ratio | -21.75% | 0.52% | 3.06% | 0.73% | 0.41% | 7.75% | 7.34% | 6.59% | 6.96% | 6.98% | 6.53% | 7.45% | 6.66% | 5.61% | 3.49% | 3.55% |
| Income Tax Expense | -365.57B | 143.95B | 102.99B | 52.93B | 22.43B | 175.93B | 118.00B | 111.43B | 85.16B | 79.08B | 68.48B | 72.52B | 60.24B | 39.89B | 37.22B | 40.71B |
| Net Income | -1,485.56B | -94.33B | 302.27B | 17.64B | 15.89B | 415.90B | 326.79B | 267.41B | 248.85B | 234.63B | 214.55B | 205.13B | 171.77B | 138.72B | 62.51B | 55.39B |
| Net Income Ratio | -14.91% | -0.98% | 2.35% | 0.18% | 0.17% | 5.58% | 5.33% | 4.60% | 5.12% | 5.19% | 4.93% | 5.49% | 4.93% | 4.36% | 2.19% | 2.05% |
| EPS | -267.48 | -16.98 | 54.42 | 3.18 | 2.86 | 74.88 | 58.84 | 48.15 | 47.07 | 46.08 | 38.63 | 36.93 | 30.93 | 24.98 | 11.25 | 9.97 |
| EPS Diluted | -267.48 | -16.98 | 54.42 | 3.18 | 2.86 | 74.88 | 58.84 | 48.15 | 47.07 | 46.08 | 38.63 | 36.93 | 30.93 | 24.98 | 11.25 | 9.97 |
| Weighted Avg Shares Out | 5.55B | 5.55B | 5.55B | 5.55B | 5.55B | 5.55B | 5.55B | 5.55B | 5.55B | 5.55B | 5.55B | 5.55B | 5.55B | 5.55B | 5.55B | 5.55B |
| Weighted Avg Shares Out (Dil) | 5.55B | 5.55B | 5.55B | 5.55B | 5.55B | 5.55B | 5.55B | 5.55B | 5.55B | 5.55B | 5.55B | 5.55B | 5.55B | 5.55B | 5.55B | 5.55B |
Source: https://incomestatements.info
Category: Stock Reports